查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
細胞和基因療法市場：按治療類型、按應用、按最終用戶、按地區：規模、份額、前景、機會分析，2023-2030 年
市場調查報告書
商品編碼
1349969

細胞和基因療法市場：按治療類型、按應用、按最終用戶、按地區：規模、份額、前景、機會分析，2023-2030 年

Cell and Gene Therapy Market, By Therapy Type, By Application, By End User, By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 247 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2023 年，全球細胞和基因治療市場將達到 227 億美元，預測期內（2023-2030 年）複合年增長率為 28.7%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 美國：227億美元
之前的數據 2018年至2021年 預測期 2023-2030
預測 2023-2030 年複合年增長率： 28.70% 2030年價值預測 美國：1326億美元
細胞和基因治療市場-IMG1

細胞療法是將新細胞引入患者體內，使其生長、替換和修復受損組織，進而治療疾病。細胞療法可以使用許多不同類型的細胞，包括幹細胞、淋巴細胞和樹突狀細胞。細胞療法使用取自患者自身的細胞（自體細胞）和取自捐贈者的細胞（同種異體細胞）。許多細胞療法使用經過基因重新編程的成體細胞，這些細胞可以成為患者體內多種類型細胞中的任何一種。這項技術有潛力開發出無限數量的治療目的所需的特定人類細胞。

基因療法試圖修改或將基因引入患者體內以治療、預防或潛在治癒疾病。基因治療方法的例子包括以功能性拷貝取代致病突變基因，或將新的、正確的基因拷貝引入體內。

市場動態

細胞和基因療法在現代醫療保健中發揮著重要作用，因為它提供了可用於基因調控、細胞間相互作用、再生能力和重塑的概念和技術。因此，主要市場參與者正專注於實施各種成長策略，例如產品/平台發布，預計將在預測期內推動市場成長。例如，2023 年 4 月 4 日，全球醫療保健公司 AmerisourceBergen 宣布推出細胞與基因治療 (CGT) 整合中心。該系統可以與生物製藥和提供者的平台集成，以促進即時數據交換，並協助整個患者旅程中的治療開發和服務編排。

本研究的主要特點

  • 該報告對全球細胞和基因治療市場進行了詳細分析，並提出了以2022年為基準年的預測期（2023-2030）的市場規模和複合年增長率（CAGR）。
  • 它還揭示了各個細分市場的潛在收入機會，並為該市場提供了一系列有吸引力的投資建議。
  • 它還提供了有關市場驅動因素、限制因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採取的競爭策略等的重要見解。
  • 根據公司亮點、產品組合、主要亮點、財務表現和策略等參數對全球細胞和基因治療市場的主要參與者進行了分析。
  • 本研究涵蓋的主要公司包括Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., Bluebird Bio, Inc.（Celgene Corporation）, Biogen Inc., uniQure N.V., JCR Pharmaceuticals Co. Ltd., Gene Biotherapeutics, Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Organogenesis, Inc., Orchard Therapeutics Plc., Freeline Therapeutics Ltd. , Bristol-Myers Squibb Company, PTC Therapeutics, Inc., Spark Therapeutics, Inc. and Biomarin Pharmaceutical Inc.
  • 該報告的見解使行銷人員和公司高管能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球細胞和基因治療市場報告迎合了該行業的各種利益相關者，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
  • 利害關係人可以透過用於分析全球細胞和基因治療市場的各種策略矩陣來促進他們的決策。

目錄

第一章 研究目的與前提

  • 研究目標
  • 先決條件
  • 縮略語

第二章 市場概況

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要
  • 連貫的機會地圖 (COM)

第三章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進者
    • 抑製劑
    • 市場機會
  • 影響分析
  • 合併、收購、聯盟
  • 監管場景
  • 重大發展
  • PEST分析
  • 技術進步
  • 製造商收入
  • 管道分析

第 4 章 全球細胞與基因治療市場 - COVID-19 影響分析

  • 經濟影響
  • COVID-19 流行病學
  • 對供需的影響

第五章全球細胞與基因治療市場：依治療類型，2018-2030

  • 細胞療法
  • 幹細胞
  • T細胞
  • 樹突狀細胞
  • 自然殺手細胞
  • 基因治療
  • 生殖細胞基因治療
  • 體細胞基因治療

第六章 全球細胞與基因治療市場：依應用分類，2018-2030

  • 皮膚科
  • 肌肉骨骼系統
  • 腫瘤學
  • 免疫學
  • 心臟病學/神經病學
  • 其他（泌尿系統疾病、傳染病、眼科疾病、視網膜疾病等）

第 7 章 全球細胞與基因治療市場：依最終使用者劃分，2018-2030 年

  • 醫院
  • 診所
  • 其他（研究機構、學術機構等）

第 8 章 全球細胞與基因治療市場：按地區劃分，2018-2030 年

  • 北美
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 歐洲
  • 英國
  • 德國
  • 意大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東盟
  • 澳大利亞
  • 韓國
  • 亞太其他地區
  • 中東
  • 海灣合作委員會
  • 以色列
  • 其他中東
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭格局

  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • Amgen, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Bluebird Bio, Inc.（Celgene Corporation）
  • Biogen Inc.
  • uniQure N.V.
  • JCR Pharmaceuticals Co. Ltd.
  • Gene Biotherapeutics
  • Kolon TissueGene, Inc.
  • Horama S.A.
  • MeiraGTx Limited
  • Gilead Sciences, Inc.
  • Organogenesis, Inc.
  • Orchard Therapeutics Plc.
  • Freeline Therapeutics Ltd.
  • Bristol-Myers Squibb Company
  • PTC Therapeutics, Inc.
  • Spark Therapeutics, Inc.
  • Biomarin Pharmaceutical Inc.

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI2475

The global cell and gene therapy market is estimated to be valued at US$ 22.7 billion in 2023 and is expected to exhibit a CAGR of 28.7% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 22.7 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 28.70% 2030 Value Projection: US$ 132.6 Bn
Cell and Gene Therapy Market - IMG1

Cell therapy is the introduction of new cells into a patient's body to grow, replace, or repair damaged tissue in order to treat a disease. A variety of different types of cells can be used in cell therapy, including stem cells, lymphocytes, and dendritic cells. Cell therapies can use cells from the patient's own body (autologous) or from a donor (allogenic). Many cell therapies use adult cells that have been genetically reprogrammed and capable of becoming one of many types of cells inside a patient's body. This technology may enable the development of unlimited types of specific human cells needed for therapeutic purposes.

Gene therapy seeks to modify or introduce genes into a patient's body with the goal of treating, preventing, or potentially curing a disease. Examples of gene therapy approaches include replacing a mutated gene that causes disease with a functional copy or introducing a new, correct copy of a gene into the body.

Market Dynamics

Cell and gene therapy plays a major role in modern healthcare, as it provides concepts and techniques that can be used in gene regulation, cell-cell interactions, regenerative capacity, and remodeling. Thus, key market players are focused on adopting various growth strategies such as product/platform launches and others, which in turn is expected to fuel the market growth over the forecast period. For instance, on April 4, 2023, AmerisourceBergen, a global healthcare company, announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integrated with biopharma or provider-facing platforms to facilitate real-time data exchange and help orchestrate services across the treatment development and patient journey.

Furthermore, The CGT Integration Hub, which is platform-agnostic and powered by AmerisourceBergen's innovative customer relationship management (CRM) system, aims to streamline the path-to-care process, in part, by providing physicians and patient services teams with enhanced visibility across the therapy development and delivery process. Through platform integrations, the CGT Integration Hub can:

  • Speed up the benefits investigation process so that after physicians enter patient enrollment data, they can get a decision on the patient's coverage almost immediately.
  • To facilitate patient scheduling, give doctors and care managers real-time access to information on the status of the development of the therapy and transportation.
  • Inform case managers of any status changes, such as postponed arrival dates, so they can contact patients and caregivers in advance to amend any scheduled treatment-related activities or stays, as necessary.

Key features of the study:

  • This report provides an in-depth analysis of the global cell and gene therapy market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell and gene therapy market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., Bluebird Bio, Inc. (Celgene Corporation) , Biogen Inc., uniQure N.V., JCR Pharmaceuticals Co. Ltd., Gene Biotherapeutics, Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Organogenesis, Inc., Orchard Therapeutics Plc., Freeline Therapeutics Ltd. , Bristol-Myers Squibb Company, PTC Therapeutics, Inc., Spark Therapeutics, Inc. and Biomarin Pharmaceutical Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cell and gene therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell and gene therapy market

Detailed Segmentation:

  • Global Cell and Gene Therapy Market, By Therapy Type:
    • Cell Therapy
    • Stem Cells
    • T Cells
    • Dendritic Cells
    • NK Cells
    • Gene Therapy
    • Germline Gene Therapy
    • Somatic Gene Therapy
  • Global Cell and Gene Therapy Market, By Application:
    • Dermatology
    • Musculoskeletal
    • Oncology
    • Immunology
    • Cardiology & Neurology
    • Others (Urinary Problems, Infectious Disease, Ophthalmic, Diseases, Retinal Diseases, And Others)
  • Global Cell and Gene Therapy Market, By End user:
    • Hospitals
    • Clinics
    • Others (Research Institutes, Academic Institutes, etc.)
  • Global Cell and Gene Therapy Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Novartis International AG
    • Pfizer, Inc.
    • Sanofi S.A.
    • Amgen, Inc.
    • Regeneron Pharmaceuticals, Inc.
    • Bluebird Bio, Inc. (Celgene Corporation)
    • Biogen Inc.
    • uniQure N.V.
    • JCR Pharmaceuticals Co. Ltd.
    • Gene Biotherapeutics
    • Kolon TissueGene, Inc.
    • Horama S.A.
    • MeiraGTx Limited
    • Gilead Sciences, Inc.
    • Organogenesis, Inc.
    • Orchard Therapeutics Plc.
    • Freeline Therapeutics Ltd.
    • Bristol-Myers Squibb Company
    • PTC Therapeutics, Inc.
    • Spark Therapeutics, Inc.
    • Biomarin Pharmaceutical Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Therapy Type
    • Market Snapshot, By Application
    • Market Snapshot, By End user
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • Technological Advancements
  • Manufacturer Revenue
  • Pipeline Analysis

4. Global Cell and Gene Therapy Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Cell and Gene Therapy Market, By Therapy Type, 2018 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Stem Cells
  • T Cells
  • Dendritic Cells
  • NK Cells
  • Gene Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Germline Gene Therapy
  • Somatic Gene Therapy

6. Global Cell and Gene Therapy Market, By Application, 2018 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Musculoskeletal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Cardiology & Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Others (Urinary Problems, Infectious Disease, Ophthalmic, Diseases, Retinal Diseases, And Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends

7. Global Cell and Gene Therapy Market, By End user, 2018 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
  • Others (Research Institutes, Academic Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)

8. Global Cell and Gene Therapy Market, By Region, 2018 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Novartis International AG*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer, Inc.
  • Sanofi S.A.
  • Amgen, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Bluebird Bio, Inc. (Celgene Corporation)
  • Biogen Inc.
  • uniQure N.V.
  • JCR Pharmaceuticals Co. Ltd.
  • Gene Biotherapeutics
  • Kolon TissueGene, Inc.
  • Horama S.A.
  • MeiraGTx Limited
  • Gilead Sciences, Inc.
  • Organogenesis, Inc.
  • Orchard Therapeutics Plc.
  • Freeline Therapeutics Ltd.
  • Bristol-Myers Squibb Company
  • PTC Therapeutics, Inc.
  • Spark Therapeutics, Inc.
  • Biomarin Pharmaceutical Inc.

10. Section

  • Research Methodology
  • About Us